Profile of Depressive Symptoms in Parkinsons Disease
- Conditions
- DepressionParkinson Disease
- Registration Number
- NCT00349310
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
To explore or establish the relationship between cognitive, mood and motor symptoms in PD to scores on depression rating scales in a naturalistic setting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1018
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HADS, HAMD-17, BDI-1A, FAB (cognitive), DSM-IV (mood- part A, B, C, E) and UPDRS Up to 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (18)
Hopital Purpan
🇫🇷Toulouse cedex, France
Boehringer Ingelheim Investigational Site
🇬🇧Newark, United Kingdom
Parkinson Klinik Wolfach
🇩🇪Wolfach, Germany
Neurologisches Fachkrankenhaus fur
🇩🇪Beelitz-Heilstatten, Germany
Hospital Puerta del Mar. Neurology
🇪🇸Cadiz, Spain
Hopital Rangueil
🇫🇷Toulouse cedex 9, France
Universitatsklinikum Carl Gustav Carus Dresden
🇩🇪Dresden, Germany
Gertrudis-Kliniken Biskirchen
🇩🇪Leun, Germany
Academisch Ziekenhuis Maastricht
🇳🇱Maastricht, Netherlands
Hospital Clinic i Provincial. Neurology
🇪🇸Barcelona, Spain
Hospital de Cruces. Neurology
🇪🇸Baracaldo / Bilbao, Spain
Hopital Cantonal (HUG)
🇨ðŸ‡Geneve, Switzerland
Clinica Hildebrand
🇨ðŸ‡Brissago, Switzerland
Kantonsspital St. Gallen
🇨ðŸ‡St.Gallen, Switzerland
Policlinico di Catania
🇮🇹Catania, Italy
Azienda Ospedaliera S. Martino
🇮🇹Genova, Italy
Universita Federico II
🇮🇹Napoli, Italy
Universita La Sapienza di Roma
🇮🇹Roma, Italy